In-silico molecular design of heterocyclic benzimidazole scaffolds as prospective anticancer agents

MLA

Sumit Tahlan, et al. “In-Silico Molecular Design of Heterocyclic Benzimidazole Scaffolds as Prospective Anticancer Agents.” BMC Chemistry, vol. 13, no. 1, July 2019, pp. 1–22. EBSCOhost, https://doi.org/10.1186/s13065-019-0608-5.

APA

Sumit Tahlan, Sanjiv Kumar, Kalavathy Ramasamy, Siong Meng Lim, Syed Adnan Ali Shah, Vasudevan Mani, & Balasubramanian Narasimhan. (2019). In-silico molecular design of heterocyclic benzimidazole scaffolds as prospective anticancer agents. BMC Chemistry, 13(1), 1–22. https://doi.org/10.1186/s13065-019-0608-5

Chicago

Sumit Tahlan, Sanjiv Kumar, Kalavathy Ramasamy, Siong Meng Lim, Syed Adnan Ali Shah, Vasudevan Mani, and Balasubramanian Narasimhan. 2019. “In-Silico Molecular Design of Heterocyclic Benzimidazole Scaffolds as Prospective Anticancer Agents.” BMC Chemistry 13 (1): 1–22. doi:10.1186/s13065-019-0608-5.